Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Role of High Mobility Group Box 1 in Cardiovascular Diseases

Inflammation(2022)10.1007/s10753-022-01668-3Source: DataRank Database

Role of High Mobility Group Box 1 in Cardiovascular Diseases is a research paper published in Inflammation (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.37)OA: greenTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Khalid Matrougui ORCID,Souad Belmadani ORCID

Live enrichment

PubMed:35386038 PMC:PMC11145736 OpenAlex:https://openalex.org/W4226113789

National Institutes of Health

Grant: HL150014

National Institutes of Health

Grant: HL151616

NHLBI NIH HHS

Grant: R01 HL151616

NHLBI NIH HHS

Grant: R01 HL150014

National Institutes of Health

Grant: 6R01HL150014-05

Interleukin 12 disruption provides beta cell and microvessel protection in type 2diabetes

National Institutes of Health

Grant: 1R01HL151616-01

Stromal interaction molecule 1, immune cells, and vascular pathology in established hypertension

FWCI

1.37

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Springer TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11145736

publisherhttps://link.springer.com/content/pdf/10.1007/s10753-022-01668-3.pdf

publisherhttps://link.springer.com/article/10.1007/s10753-022-01668-3/fulltext.html

journalhttps://doi.org/10.1007/s10753-022-01668-3

Fields of Study

Advanced Glycation End Products researchAtherosclerosis and Cardiovascular DiseasesInflammatory mediators and NSAID effects0301 basic medicine0303 health sciences03 medical and health sciencesCardiovascular DiseasesCell NucleusCytoplasmHMGB1 ProteinHumansInflammation

MeSH Terms

Cardiovascular DiseasesCell NucleusCytoplasmHumansInflammationHMGB1 Protein

Keywords

HMGB1High-mobility groupInflammationCytosolCytoplasmBiologyCell biologyIntracellularNuclear proteinBioinformaticsComputational biologyNeuroscienceImmunologyGeneticsBiochemistryTranscription factorDiabetescardiovascularAngiogenesis.Cell NucleusCardiovascular DiseasesHumansHMGB1 Protein

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Role of High Mobility Group Box 1 in Cardiovascular Diseases

FAIR Checklist

Authors (2)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)